Bernard Masquelier

Overview

Best Publications

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  492
  Citations

• Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

  Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  420
  Citations

• European guidelines on the clinical management of HIV-1 tropism testing

  L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  324
  Citations

• Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

  Elise Arrivé;Marie-Louise Newell;Didier K Ekouevi;Marie-Laure Chaix

  304
  Citations

• Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

  Mayaux Mj;Burgard M;Teglas Jp;Cottalorda J

  204
  Citations

• Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

  Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  159
  Citations

• Human Immunodeficiency Virus Type 1 Genotypic and Pharmacokinetic Determinants of the Virological Response to Lopinavir-Ritonavir-Containing Therapy in Protease Inhibitor-Experienced Patients

  Bernard Masquelier;Dominique Breilh;Didier Neau;Sylvie Lawson-Ayayi

  150
  Citations

• Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

  Marie-Laure Chaix;Diane Descamps;Martine Harzic;Véronique Schneider

  147
  Citations

• The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

  Pillay D;Bhaskaran K;Jurriaans S;Prins M

  142
  Citations

• French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

  Diane Descamps;Marie-Laure Chaix;Patrice André;Véronique Brodard

  141
  Citations

• Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.

  Olivia Peuchant;Rodolphe Thiébaut;Sophie Capdepont;Valérie Lavignolle-Aurillac

  136
  Citations

• Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

  Marie-Laure Chaix;Diane Descamps;Marc Wirden;Laurence Bocket

  121
  Citations

• Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

  Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford

  111
  Citations

• Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT Inhibitors

  Bernard Masquelier;Esther Race;Catherine Tamalet;Diane Descamps

  104
  Citations

• HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens

  Daniel da Silva;Liesbeth Van Wesenbeeck;Dominique Breilh;Sandrine Reigadas

  98
  Citations

• Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

  Diane Descamps;Marie-Laure Chaix;Brigitte Montes;Sophie Pakianather

  95
  Citations

• Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens.

  B Lina;B Pozzetto;L Andreoletti;E Beguier

  93
  Citations

• Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

  Patricia Recordon-Pinson;Cathia Soulié;Philippe Flandre;Diane Descamps

  93
  Citations

• Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.

  Samir Vora;Anne-Geneviève Marcelin;Huldrych F. Günthard;Philippe Flandre

  92
  Citations

• Clinically relevant interpretation of genotype for resistance to abacavir.

  Françoise Brun-Vézinet;Diane Descamps;Annick Ruffault;Bernard Masquelier

  86
  Citations

• Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.

  Isabelle Pellegrin;Elisabeth Legrand;Didier Neau;Pascal Bonot

  85
  Citations